Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?

Emerging Infectious Diseases

Volumn 4, Issue 2, 1998, Pages 221-227

  Holmes, Alison ^a   Govan, John ^b   Goldstein, Richard ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; GENE INSERTION; GEOGRAPHIC DISTRIBUTION; NONHUMAN; REVIEW; SOIL TREATMENT; STRAIN DIFFERENCE; TAXONOMY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0031807326     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0402.980209     Document Type: Review

References (52)

1. Burkholder W. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950;40:115-8.
2. Goldmann D, Klinger J. Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiology. J Pediatr 1986;108:806-12.
3. Thomassen MJ, Demko C, Klinger, J, Stern, R. Pseudomonas cepacia colonization among patients with cystic fibrosis - a new opportunist. Am Rev Respir Dis 1985;131:791-6.
4. Sajjan U, Sun L, Goldstein R, Forstner J. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995;177:1030-8.
5. Pseudomonas cepacia - more than a harmless commensal? [editorial]. Lancet 1992;329:1385-6.
6. Govan J, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiological Reviews 1996;60:539-74.
7. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-10.
8. Tablan O, Chorba T, Schidlow D, White J, Hardy K, Gilligan P, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985;107:382-7.
9. Thomassen MJ, Demko C, Doershuk C, Stern R, Klinger J. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis 1986;134:669-71.
10. Tablan O, Martone W, Coershuk D, Stern R, Thomassen MJ, Klinger J, et al. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Chest 1987;91:527-32.
11. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada. Am J Epidemiol 1996;143:1007-17.
12. Govan J, Brown P, Maddison J, Doherty C, Nelson J, Dodd M, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
13. Walters S, Smith E. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet 1993;342:3-4.
14. Hearst J, Elliott K. Identifying the killer in cystic fibrosis. Understanding the genetic defects underlying CF is only half the battle. Identifying the specific bacterium infecting CF patients is just as important. Nature Medicine 1995;1(No. 7):626-7.
15. LiPuma J, Mortensen J, Dasen, S, Stull T. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatrics 1988;113:859-62.
16. Johnson W, Tyler S, Rozee K. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994;32:924-30.
17. Mahenthiralingam E, Simpson D, Speert D. Identification and characterisation of a novel DNA marker associated with epidemic strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-16.
18. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1995;1:661-6.
19. Pitt T, Kaufmann M, Patel P, Benge L, Gaskin S, Livermore D. Type characterization and antibiotic susceptibility of Burkholderia (pseudomonas) cepacia isolated from patients with cystic fibrosis in the United Kingdom and Republic of Ireland. J Med Microbiol 1996;44:203-10.
20. Segonds C, Bingen, B, Couetdic G, Mathy S, Brahimy N, Narty N, et al. Genotypic Analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol 1997;35:2055-60.
21. Steinbach S, Sun L, Jiang R, Flume P, Gilligan P, Egan T, et al. Transmissibility of Pseudomonas cepacia infections in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994;331:981-7.
22. Ryley H, Ojeniyi B, Hoiby N, Weeks J. Lack of evidence of cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996;15:755-9.
23. Govan J, Hughes J, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996;45:395-407.
24. Taplin D, Bassett D, Mertz P. Foot lesions associated with Pseudomonas cepacia. Lancet 1971;568-71.
25. Jarvis W, Olson D, Tablan O, Martone J. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987;3:233-6.
26. Anderson D, Kuhns J, Vasil M, Gerding D, Janoff E. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 1991;29:648-9.
27. Pegues D, Carson L, Anderson R, Norgard M, Argent T, Jarvis W, et al. Outbreak of Pseudomonas cepacia in oncology patients. Clin Infect Dis 1993;16:407-14.
28. Dixon R, Ksalow D, Mackel C, Fulkerson C, Mollison G. Aqueous quaternary ammonium antiseptics and disinfectants - use and misuse. JAMA 1977;236:2415-7.
29. Sobel J, Hashman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 1982;73:183-6.
30. Hyde J, Humphreys H. Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1997;16:253-4.
31. Holmes A, Nolan R, Finley R, Riley M, Sun L, Goldstein R. An epidemic clone of Burkholderia (Pseudomonas) cepacia transmitted between cystic fibrosis and non-cystic fibrosis patients. In Abstracts of the 9th Annual North American Cystic Fibrosis Conference; 1995; Dallas, Texas. Dallas (TX): Cystic Fibrosis Foundation; 1995, abstract 228.
32. Tablan O, Chorba T, Schidlow D, White J, Hardy K, Gilligan P, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1984;107:382-7.
33. Carson L, Tablan O, Cusick L, Jarvis W, Favero M, Bland L. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental source. J Clin Microbiol 1988;26:2096-100.
34. Gilligan P, Gage P, Bradshaw L, Schidlow D, DeCicco B. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1985;22:5-8.
35. McLoughlin T, Quinn J, Bettermann A, Bookland R. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling disease. Appl Environ Microbiol 1992;58:1760-3.
36. Homma Y, Sato Z, Hirayama F, Kanno K, Shirahama H, Suzui T. Production of antibiotics by Pseudomonas cepacia as an agent for biological control of soilborne pathogens. Soil Biology and Biochemistry 1989;21:723-8.
37. Sangodkar U, Chapman P, Chakrabarty A. Cloning, physical mapping and expression of chromosomal genes specifying degradation of the herbicide 2,4,5-T by Pseudomonas cepacia AC1100. Gene 1988;71:267-77.
38. Tabacchioni S, Visca P, Chiarini L, Bevivino A, Di Serio C, Francelli S, et al. Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol 1995;146:531-42.
39. Bowers J, Parke J. Epidemiology of Pythium damping-off and Aphanomyces root rot of peas after seed treatment with bacterial agents for biological control. Phytopathology 1993;83:1466-73.
40. King E, Parke J. Population density of the biocontrol agent Burkholderia cepacia AMMDR1 on four pea cultivars. Soil Biology and Biochemistry 1996;28:306-12.
41. Joy A, Parke J. Biocontrol of Alternaria leaf blight on American ginseng by Burkholderia cepacia AMMD. In: Bailey WG, Whitehead C, Procter JTA, Kyle JT, editors. Challenges of the 21st century. Proceedings of the International Ginseng Conference; 1994; Vancouver, British Columbia, Canada. Burnaby, B.C., Canada: Simon Fraser Univ.; 1994.
42. Cartwright D, Chilton C, Benson D. Pyrrolnitrin and phenazine production by Pseudomonas cepacia strain 5.5B, a biocontrol agent of Rhizoctonia solani. Appl Microbiol Biotechnol 1995;43:211-6.
43. Reddy M. Status on commercial development of Burkholderia cepacia for biological control of fungal pathogens and growth enhancement of conifer seedlings for a global market. Washington: US Forest service general technical report PNW; 1997. Report no. 389. p. 235-44.
44. Wise M, Shimkets L, McArthur J. Genetic structure of a lotic population of Burkholderia (Pseudomonas) cepacia. Appl Environ Microbiol 1995;61:1791-8.
45. Ursing JB, Rosello-Mora RA, Garcia-Valdes E, Lalcut J. A pragmatic approach to the nomenclature of phenotypically similar genomic groups. Int J Syst Bacteriol 1995;45:604.
46. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp nov. Int J Syst Bacteriol 1997;47:1188-200.
47. Cheng H, Lessie T. Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol 1994;176:4034-2.
48. Holmes A, Zhou H, Sun L, Goldstein R. Multiple chromosome variability amongst clinical and environmental isolates of Burkholderia (Pseudomonas) cepacia; Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1996; San Francisco. San Francisco: ICAAC; 1995; Abstract C51.
49. Allardet-Servent A, Michaux-Charachon S, Jumas-Bilak E, Karayan L, Ramuz M. Presence of one linear and one circular chromosome in the Agrobacterium tumefaciens C58 genome. J Bacteriol 1993;175:7869-74.
50. Suwanto A, Kaplan S. Physical and genetic mapping of the Rhodobacter sphaeroides 2.4.1 genome: genome size, fragment identification, and gene localisation. J Bacteriol 1989;171:5840-9.
51. Michaux S, Paillisson J, Charles-Nurit M, Bourg G, Allardet-Servent A, Ramuz M. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol 1993;175:701-5.
52. Mark K, Titball R. The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia. FEMS Microbiol Letts. In press 1998.